Questran Light

   
Google
 
Web NewDrugInformation.com

Questran Light


Drug - Questran Light
The trade name of the product as shown on the labeling.

Dosage - POWDER; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cholestyramine
Multiple ingredients are in alphabetical order.

Strength - EQ 4GM RESIN/SCOOPFUL
The potency of the active ingredient(s), Cholestyramine. May repeat for multiple part products.

Applicant - BRISTOL MYERS
The firm name holding legal responsibility for Questran Light. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019669
The FDA assigned number to Questran Light. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Questran Light. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 5, 1988
The date Questran Light was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Questran Light. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Questran Light is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Myers Co
The full name of the firm holding legal responsibility for the new application of Questran Light.

Questran Light